Evidence is not (yet) enough for evidence based policy for chlamydia screening

BMJ 2001; 322 doi: 10.1136/bmj.322.7282.364/a (Published 10 February 2001)
Cite this as: BMJ 2001;322:364.2

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. ClaSS Study Group
  1. ClaSS Co-ordinating Centre, Department of Social Medicine, University of Bristol, Bristol BS8 2PR

    EDITOR—Pimenta et al, in their evidence based health policy report, argue that opportunistic screening for Chlamydia trachomatis, targeting young women in primary care, “heralds the approach that is required to manage the wide variety of sexual health issues that confront us today.”1 This conclusion is premature when the pilot studies described are not completed and unanswered questions remain.

    It is uncertain whether opportunistic screening of young women can control the chlamydia epidemic. The only randomised trial of screening did not evaluate an opportunistic approach and included in the analysis only a small proportion of the women randomised.2 Opportunistic screening in Sweden did reduce rates of infections and complications,3 but recent figures indicate a resurgence …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL